Navigation Links
Aptium Oncology Names New Chief Operating Officer
Date:6/8/2009

Paul O'Dea, VP and Executive Director of Cedars-Sinai Outpatient Cancer Center Appointed COO

LOS ANGELES, June 8 /PRNewswire-USNewswire/ -- Aptium Oncology today announced the appointment of Paul R. O'Dea to the position of Chief Operating Officer (COO). O'Dea was formerly Vice President, Aptium Oncology and Executive Director, Cedars-Sinai Outpatient Cancer Center, part of the Aptium network of hospital-based cancer centers. The appointment was effective June 1, 2009.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090608/DC28167)

"Paul has consistently distinguished himself throughout his 20-year career with Aptium Oncology," says Peter Jessup, Chief Executive Officer, Aptium Oncology. "His leadership abilities, combined with his extensive knowledge and keenly strategic insights into our operations will be a tremendous asset that stand him in good stead for this position. I'm confident that Aptium's commitment to advancing comprehensive cancer services and patient care of the highest quality will continue to thrive with Paul as our COO."

O'Dea joined Aptium Oncology in 1989 as Pharmacy Director of Cedars-Sinai Outpatient Cancer Center (CSOCC) at the Samuel Oschin Comprehensive Cancer Institute in Los Angeles, California. He was appointed the Center's Associate Executive Director of Operations in 1996, and promoted to Executive Director of Operations in 1997.

"I appreciate the many opportunities provided to me throughout my career with Aptium Oncology and look forward to bringing that experience to the COO position through operational excellence, enhanced patient care and business value," says O'Dea. "With its innovative offering of comprehensive patient care services, ongoing process improvements and new programs, Aptium is well positioned to help achieve better lives for cancer patients and their families."

Prior to joining Aptium Oncology, O'Dea held pharmacy positions with several prestigious health care institutions including nine years with the University of California, Los Angeles (UCLA). He received his Bachelor of Science in Pharmacy from the University of Connecticut in 1969. O'Dea has published and presented extensively. He is also a member of numerous professional organizations including the California Society of Health Systems Pharmacists, American Society of Health Systems Pharmacists, Health Care Executives of Southern California and the American College of Healthcare Executives, the Association of Cancer Executives, and a delegate member of the Association of Community Cancer Centers.

About Aptium Oncology

Aptium Oncology has 25 years of experience managing outpatient oncology services at leading medical institutions throughout the United States. Aptium Oncology is a pioneer in designing, building and managing comprehensive cancer centers with a steadfast vision to transform cancer care environments by bringing every necessary service to one central place. The intent of this single place is to help patients achieve longer, better lives. Aptium Oncology's corporate headquarters is located in Los Angeles, California. For more information, visit www.aptiumoncology.com.


'/>"/>
SOURCE Aptium Oncology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology: